Sign in

NCT07720388Recruiting

Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language Training Initiative

Source: ClinicalTrials.gov · Last updated 30 Oct 2026

Brief summary (registry, in English)

This study plans to learn more about whether a support program delivered in Spanish or both English and Spanish for bilingual families helps Latino youth with Type 1 Diabetes (T1D) successfully use the Medtronic MiniMed 780G system. The main question it aims to answer is: Does a linguistically and culturally tailored onboarding model for an automated insulin delivery system close the gap in technology adoption and improve health outcomes? Participants will: * Use the Medtronic MiniMed 780G Automated Insulin Delivery system for eight months * Attend one in-person nutrition support and insulin pump start class * Participate in regular virtual check-ins with native Spanish-speaking study team members

Status (registry)
Recruiting
Study type
Interventional
Enrollment
15 (estimated)
First submitted
17 Jul 2026
Start date
2 Oct 2026
Primary completion date
31 Jul 2027
Lead sponsor
University of Colorado, Denver
NCT number
NCT07720388

What you commit to

  • Study type: Interventional
  • Planned participants: 15
  • From 2 Oct 2026 to the primary completion date, 31 Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of any significant medical condition that, in the opinion of the investigator, would interfere with study participation or data interpretation

Other

  • Current use of any Medtronic technology
  • More than 1 episode of diabetic ketoacidosis (DKA) within 12 months of study enrollment
  • Current pregnancy (self-reported), due to limited safety data for use of the Medtronic MiniMed 780G system during pregnancy
  • Inability or unwillingness to use the Medtronic MiniMed 780G system for the duration of the study

Who the study is looking for

  • Age 10 - 20 years old
  • Diagnosis of type 1 diabetes
  • Self-identify as Latino/Hispanic (determined via self-report and/or electronic health record)
  • Currently managing diabetes using any regimen, including multiple daily injections (MDI) or any non-Medtronic automated insulin delivery system
  • Willing to transition to and use the Medtronic MiniMed 780G system for the duration of the study

Age in the registry: 10 years to 20 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Barbara Davis Center
Coordinator of this site? Confirm its status
AuroraUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.